PYRROLIDINE-3-CARBOXAMIDE DERIVATIVES AND RELATED USES
The present disclosure relates to compounds of Formula (I′):and to their prodrugs, pharmaceutically acceptable salts, pharmaceutical compositions, methods of use, and methods for their preparation. The compounds disclosed herein are useful for the treatment of a viral infection (e.g., hepatitis B virus or a Flaviviridae virus)..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Europäisches Patentamt - (2023) vom: 07. Dez. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
RUENGSATRA TANACHOTE [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-12-07, Last update posted on www.tib.eu: 2023-12-22, Last updated: 2023-12-29 |
|---|
| Patentnummer: |
US2023391752 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA018828051 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA018828051 | ||
| 003 | DE-627 | ||
| 005 | 20231229105047.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231222s2023 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA018828051 | ||
| 035 | |a (EPA)US2023391752 | ||
| 035 | |a (EPA)78806632 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a RUENGSATRA TANACHOTE |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a PYRROLIDINE-3-CARBOXAMIDE DERIVATIVES AND RELATED USES |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2023-12-07, Last update posted on www.tib.eu: 2023-12-22, Last updated: 2023-12-29 | ||
| 520 | |a The present disclosure relates to compounds of Formula (I′):and to their prodrugs, pharmaceutically acceptable salts, pharmaceutical compositions, methods of use, and methods for their preparation. The compounds disclosed herein are useful for the treatment of a viral infection (e.g., hepatitis B virus or a Flaviviridae virus). | ||
| 650 | 4 | |a C07D: Heterocyclic compounds (macromolecular compounds c08) | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a RATTANANGKOOL EAKKAPHON |4 aut | |
| 700 | 0 | |a CHAIYAKUNVAT PONGKORN |4 aut | |
| 700 | 0 | |a DEESIRI SIRIKAN |4 aut | |
| 700 | 0 | |a DUNKOKSUNG WILASINEE |4 aut | |
| 700 | 0 | |a UDOMNILOBOL UDOMSAK |4 aut | |
| 700 | 0 | |a CHUAYPEN NATTHAYA |4 aut | |
| 700 | 0 | |a TANGKIJVANICH PISIT |4 aut | |
| 700 | 0 | |a PUDHOM KHANITHA |4 aut | |
| 700 | 0 | |a PRUEKSARITANONT THOMAYANT |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 07. Dez. |
| 773 | 1 | 8 | |g year:2023 |g day:07 |g month:12 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/78806632/publication/US2023391752A1?q=US2023391752 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 936 | u | w | |j 2023 |b 07 |c 12 |
| 951 | |a AR | ||
| 952 | |j 2023 |b 07 |c 12 | ||